Excelsior Sciences Company
Excelsior Sciences develops a chemistry and AI platform for discovering and manufacturing small-molecule compounds. It uses a proprietary “smart bloccs” system, which consists of modular, machine-ready chemical building blocks, to convert small-molecule innovation into an iterative, automation-friendly workflow. Through this platform, Excelsior enables closed-loop cycles of AI-guided synthesis, testing, and optimisation that link early-stage discovery to scalable manufacturing. The company supports projects across pharmaceuticals, materials science, and other sectors that rely on small molecules. Excelsior also maintains an internal pipeline of therapeutic candidates while working with partners to deploy its chemistry platform broadly.
Total Funding:
95000000
Founded Date:
2024-01-01
Industry:
Quantum Chemistry
Employee Number:
11-50
Last Funding Date:
2025-12-03
Funding Status:
private
Headquarters:
New York,New York,United States,North America
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
95000000
Last Funding Total Usd:
70000000
Last Funding Total Currency:
USD
Last Funding Total Value:
70000000
Founders:
Bartosz Grzybowski,Jana Jensen,Martin Burke,Michael Foley